Pharma & Human Health
-
-
Pharma & Human Health -
Pharma & Human Health -
Finance -
Pharma & Human Health
Editor’s Choice
Editor's Choice
Ferring and Rebiotix Present Landmark Phase 3 Data
Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented results from the pivotal Phase 3 PUNCH™ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) […]
Editor's Choice
Fecal transplant turns cancer immunotherapy non-responders into responders
Video Credits: UNIVERSITY OF PITTSBURGH Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut microbiome can transform patients with advanced melanoma who never responded to immunotherapy–which […]
Editor's Choice
Why microbiota samples should be collected in all clinical trials?
In recent years, the understanding of how the microbiome and human health are linked has expanded considerably. We believe the rise in this understanding and the growing interest towards our microbiome research-focused Health for Life […]
In Case you Missed it:
Finance
Seres Therapeutics Announces FDA Clearance of IND for Investigational Microbiome Therapeutic for the Prevention of Antibiotic-Resistant Bacterial Infections and GvHD
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announces the U.S. Food and Drug Administration (FDA) has indicated studies for SER-155 may proceed under an Investigational New Drug (IND) application. SER-155 is an […]
Pharma & Human Health
Global microbiome study discovers thousands of new species, maps urban antimicrobial resistance and reveals new drug candidates
About 12,000 bacteria and viruses collected in a sampling from public transit systems and hospitals around the world from 2015 to 2017 had never before been identified, according to a study by the International MetaSUB […]
Bacthera
Bacthera Receives Manufacturing Licenses in Switzerland and Denmark
Basel, Switzerland and Hørsholm, Denmark, 31 May 2021 – Following GMP inspections by Swissmedic at Bacthera’s drug product facility in Basel, Switzerland, and by the Danish Medicines Agency at Bacthera’s drug substance facility in Hørsholm, […]
Finance
COVID-19 brings further evidence on the importance of microbes for our health
While the consequences of the COVID-19 pandemic have been devastating, it has also served as a key milestone on the road to understand the human microbiome and how it affects our health. Since the […]
Editor's Choice
Ferring and Rebiotix Present Landmark Phase 3 Data
Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented results from the pivotal Phase 3 PUNCH™ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) […]
